Your browser doesn't support javascript.
loading
Highly Invasive and Metastatic High-grade Endometrial Stromal Sarcoma With BCOR Gene Alterations: A Case Report.
Ling, Feng; Ruan, Sibei; Chen, Huiling; Xiong, Xiaoming; Zhao, Dongmei; Haybaeck, Johannes; Zhang, Cuiwei.
Afiliación
  • Ling F; Department of Pathology, The Affiliated Hospital of Southwest Medical University, Luzhou, P.R. China.
  • Ruan S; Department of Pathology, The Affiliated Hospital of Southwest Medical University, Luzhou, P.R. China.
  • Chen H; School of clinical medicine, Southwest Medical University, Luzhou, P.R. China.
  • Xiong X; Department of Pathology, The Affiliated Hospital of Southwest Medical University, Luzhou, P.R. China.
  • Zhao D; Department of Radiology, The Affiliated Hospital of Southwest Medical University, Luzhou, P.R. China.
  • Haybaeck J; Institute of Pathology, Neuropathology and Molecular Pathology, Medical University of Innsbruck, Innsbruck, Austria; johannes.haybaeck@i-med.ac.at zcw.37@163.com.
  • Zhang C; Diagnostic and Research Center for Molecular Biomedicine, Institute of Pathology, Medical University of Graz, Graz, Austria.
In Vivo ; 36(4): 1971-1976, 2022.
Article en En | MEDLINE | ID: mdl-35738637
BACKGROUND: The coexistence of a uterine leiomyosarcoma and a high-grade endometrial stromal sarcoma (HGESS) is extremely rare, especially when one of the components causes metastasis. CASE REPORT: A 46-year-old female with aggravated abdominal pain for more than 4 months was diagnosed with uterine malignant mesenchymal tumor composed of predominantly a leiomyosarcoma (99%) and a minor component of HGESS with BCL6 corepressor (BCOR) gene alterations (1%), with ovarian and pelvic metastases. RESULTS: The volume of HGESS with BCOR gene alterations accounted for less than 1% of the tumor mass but caused ovarian and pelvic metastases. CONCLUSION: HGESS with BCOR gene alterations is extremely aggressive. We suggest that when both components of HGESS with BCOR gene alterations and uterine leiomyosarcoma are present in one patient, the HGESS with BCOR gene alterations needs to be highlighted in the pathological report, even if it accounts for less than 1% of the tumor volume.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Uterinas / Neoplasias Endometriales / Sarcoma Estromático Endometrial / Leiomiosarcoma Tipo de estudio: Diagnostic_studies Límite: Female / Humans / Middle aged Idioma: En Revista: In Vivo Asunto de la revista: NEOPLASIAS Año: 2022 Tipo del documento: Article Pais de publicación: Grecia

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Uterinas / Neoplasias Endometriales / Sarcoma Estromático Endometrial / Leiomiosarcoma Tipo de estudio: Diagnostic_studies Límite: Female / Humans / Middle aged Idioma: En Revista: In Vivo Asunto de la revista: NEOPLASIAS Año: 2022 Tipo del documento: Article Pais de publicación: Grecia